Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Intangibles (2016 - 2025)

Surgery Partners (SGRY) has disclosed Intangibles for 13 consecutive years, with $41.0 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 10.28% to $41.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.0 million through Dec 2025, down 10.28% year-over-year, with the annual reading at $41.0 million for FY2025, 10.28% down from the prior year.
  • Intangibles hit $41.0 million in Q4 2025 for Surgery Partners, down from $45.7 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $54.8 million in Q4 2023 to a low of $41.0 million in Q4 2025.
  • Historically, Intangibles has averaged $45.5 million across 5 years, with a median of $43.7 million in 2021.
  • Biggest five-year swings in Intangibles: grew 29.55% in 2023 and later decreased 16.61% in 2024.
  • Year by year, Intangibles stood at $43.7 million in 2021, then fell by 3.2% to $42.3 million in 2022, then increased by 29.55% to $54.8 million in 2023, then decreased by 16.61% to $45.7 million in 2024, then dropped by 10.28% to $41.0 million in 2025.
  • Business Quant data shows Intangibles for SGRY at $41.0 million in Q4 2025, $45.7 million in Q4 2024, and $54.8 million in Q4 2023.